Show simple item record

dc.contributor.authorKoech, DK
dc.contributor.authorHerman, JA
dc.contributor.authorKofi-Tsekpo, MW
dc.contributor.authorHerman, SD.
dc.date.accessioned2013-06-11T09:53:34Z
dc.date.available2013-06-11T09:53:34Z
dc.date.issued1994
dc.identifier.citationAfr J Health Sci. 1994 Nov;1(4):147-150en
dc.identifier.urihttp://hinari-gw.who.int/whalecomwww.ncbi.nlm.nih.gov/whalecom0/pubmed/12153338
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/31462
dc.description.abstractDirect biological activity of a 1,2,4-trioxolane derivative was assessed in vitro using bacteria and fungi causing common infections. The product was found to be uniformly active against all organisms tested. In addition, it is active against certain tumour cells and protozoa and is also an immunomodulator. These observations are discussed in the light of the product's potential use in the clinical management of conditions in which its use is indicated.en
dc.language.isoenen
dc.publisherUniversity of Nairobi,en
dc.titleTrioxolanes: A new generation of compounds with wide-ranging activities.en
dc.typeArticleen
local.publisherCollege of Health Sciencesen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record